Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
Kaplan
Sheldon L
SL
Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D018570:Risk Assessment; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D002981:Clindamycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination